Principal Financial Group Inc. Sells 8,194 Shares of Oscar Health, Inc. (NYSE:OSCR)

Principal Financial Group Inc. trimmed its stake in shares of Oscar Health, Inc. (NYSE:OSCR) by 31.2% during the third quarter, Holdings Channel reports. The firm owned 18,072 shares of the company’s stock after selling 8,194 shares during the period. Principal Financial Group Inc.’s holdings in Oscar Health were worth $383,000 at the end of the most recent reporting period.

Several other large investors also recently modified their holdings of OSCR. Vanguard Group Inc. lifted its holdings in shares of Oscar Health by 2.4% during the first quarter. Vanguard Group Inc. now owns 14,582,762 shares of the company’s stock valued at $216,846,000 after acquiring an additional 337,850 shares during the period. Price T Rowe Associates Inc. MD increased its position in shares of Oscar Health by 153.5% during the 1st quarter. Price T Rowe Associates Inc. MD now owns 3,978,152 shares of the company’s stock worth $59,156,000 after purchasing an additional 2,409,160 shares in the last quarter. Renaissance Technologies LLC lifted its holdings in Oscar Health by 31.7% during the 2nd quarter. Renaissance Technologies LLC now owns 3,886,100 shares of the company’s stock valued at $61,478,000 after purchasing an additional 934,600 shares during the last quarter. Assenagon Asset Management S.A. boosted its position in Oscar Health by 32.9% in the second quarter. Assenagon Asset Management S.A. now owns 2,046,046 shares of the company’s stock valued at $32,368,000 after buying an additional 507,009 shares in the last quarter. Finally, Bank of New York Mellon Corp grew its stake in Oscar Health by 161.4% during the second quarter. Bank of New York Mellon Corp now owns 1,393,048 shares of the company’s stock worth $22,038,000 after buying an additional 860,226 shares during the last quarter. 75.70% of the stock is currently owned by institutional investors.

Analyst Upgrades and Downgrades

Several analysts have recently commented on OSCR shares. UBS Group assumed coverage on Oscar Health in a report on Monday, October 7th. They set a “neutral” rating and a $23.00 target price on the stock. Bank of America lowered shares of Oscar Health from a “neutral” rating to an “underperform” rating and decreased their price objective for the stock from $21.00 to $13.50 in a report on Wednesday, November 6th. Finally, Piper Sandler reaffirmed an “overweight” rating and issued a $28.00 target price on shares of Oscar Health in a research note on Tuesday, September 10th. One equities research analyst has rated the stock with a sell rating, two have issued a hold rating, four have issued a buy rating and one has issued a strong buy rating to the company. According to data from MarketBeat, Oscar Health presently has an average rating of “Moderate Buy” and an average target price of $22.93.

Oscar Health Stock Performance

NYSE:OSCR opened at $15.98 on Monday. The stock’s 50-day moving average is $17.90 and its 200-day moving average is $18.18. Oscar Health, Inc. has a 1-year low of $7.29 and a 1-year high of $23.79. The company has a current ratio of 0.73, a quick ratio of 0.73 and a debt-to-equity ratio of 0.26. The stock has a market cap of $3.95 billion, a P/E ratio of -266.33 and a beta of 1.67.

Oscar Health (NYSE:OSCR) last released its quarterly earnings results on Thursday, November 7th. The company reported ($0.22) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.20) by ($0.02). Oscar Health had a return on equity of 2.79% and a net margin of 0.35%. The firm had revenue of $2.42 billion for the quarter, compared to the consensus estimate of $2.33 billion. During the same quarter in the previous year, the business posted ($0.29) EPS. The firm’s revenue for the quarter was up 68.3% compared to the same quarter last year. Equities research analysts anticipate that Oscar Health, Inc. will post -0.01 earnings per share for the current year.

Insider Activity

In related news, Director Thrive Partners Vii Growth Gp, bought 420,819 shares of the company’s stock in a transaction on Tuesday, November 12th. The shares were purchased at an average price of $13.68 per share, for a total transaction of $5,756,803.92. Following the completion of the transaction, the director now directly owns 5,452,081 shares in the company, valued at approximately $74,584,468.08. The trade was a 8.36 % increase in their position. The transaction was disclosed in a filing with the SEC, which is accessible through this hyperlink. Also, CAO Victoria Baltrus sold 4,226 shares of the company’s stock in a transaction dated Tuesday, September 3rd. The shares were sold at an average price of $17.99, for a total value of $76,025.74. Following the sale, the chief accounting officer now owns 140,648 shares in the company, valued at approximately $2,530,257.52. This represents a 2.92 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last three months, insiders acquired 1,055,478 shares of company stock worth $14,432,852 and sold 194,569 shares worth $3,433,319. Corporate insiders own 25.11% of the company’s stock.

Oscar Health Company Profile

Oscar Health, Inc operates as a health insurance in the United States. The company offers health plans in individual and small group markets, as well as +Oscar, a technology driven platform that help providers and payors directly enable their shift to value-based care. It also provides reinsurance products.